External Drainage in Hydrocephalus Care: EVD as a Bridge to Shunting

In hydrocephalus care, external drainage often bridges the gap before a permanent shunt. Teams use an EVD when hydrocephalus is acute, when CSF is infected or heavily bloody, when the patient is not ready for implantation, or when it is unclear whether permanent diversion is needed. Weaning then shows whether the patient needs a shunt, and which one.

Why use external drainage before a permanent shunt?

A shunt is a permanent implant designed to divert CSF for years. Placing one is a considered decision, and the conditions at the time of placement matter. In many patients, those conditions are not yet right when hydrocephalus first appears. The CSF may contain blood or a high protein load after hemorrhage, it may be infected, the patient may be too unstable for elective surgery, or the cause may be temporary and resolve on its own.

External drainage solves the immediate problem while keeping the options open. It relieves pressure, allows CSF to be monitored and sampled according to protocol, and gives the team time to see how the patient evolves. If the hydrocephalus resolves, the drain is removed and no implant is needed. If it does not, the team moves to a shunt under better conditions.

Which situations commonly call for a bridge?

Guidance on healthcare-associated ventriculitis and meningitis describes removal of infected shunt hardware with external drainage as part of management, before a new shunt is placed. That pathway is one of the clearest examples of an EVD serving as a bridge.

How is the transition from EVD to shunt managed?

Transition practices vary between hospitals, but the logic is similar. Once the patient is stable, the team tests whether the patient still needs CSF diversion. Common approaches include raising the drainage threshold in steps, so that the patient drains less, and a clamping trial, in which the drain is closed while the patient is observed and imaged according to protocol.

If the patient tolerates the drain being raised or clamped, without clinical deterioration or worsening ventricular size, the drain is removed. If not, the team plans a shunt. CSF findings may also influence timing, particularly after infection or hemorrhage, and the team decides when conditions are suitable.

For the device chain, this means the EVD may be in place for some time before a decision is made. The EVD-010 Series, with its 31 cm ventricular catheter, 30 cm measuring scale, 150 ml drip chamber and 800 ml drainage bag, is available with a standard or an antibiotic-impregnated catheter. Hospitals may consider the orange antibiotic-impregnated version, designed to release the agent in a controlled way over 28 days, for drains expected to stay in longer, according to their protocol.

What does lumbar drainage add in hydrocephalus care?

In communicating hydrocephalus, where CSF pathways are open, lumbar drainage can play a different bridging role. In patients being evaluated for idiopathic normal-pressure hydrocephalus, for example, published diagnostic guidance describes supplementary tests that include a period of external lumbar drainage, used to judge whether the patient's symptoms improve with CSF removal. Improvement can support the decision to shunt.

DESU's lumbar drainage catheter kit, with an 80 cm silicone catheter, tantalum marks from 5 to 20 cm and 24 holes, can be used with the EVD-020 Series collection system for this purpose. The choice of route, and whether lumbar drainage is safe for a given patient, belongs to the clinical team; lumbar drainage is generally avoided when there is obstruction or a mass effect.

Which shunt choices follow the bridge?

When the bridge ends in a shunt, the team chooses a valve, catheters and any accessories. DESU's range covers the main choices:

• Depus shunts use a polysulfone valve with a ruby ball and titanium spring mechanism, in low, medium and high fixed pressures and in adjustable versions, in VP and LP kits. Adjustable valves are located, read and set with the Depus Adjustment Kit.
• Defit shunts are fixed-pressure, flat-bottom silicone shunts in Ultra Small, Small and Regular sizes, with low, medium and high pressure options. They contain no metal and are compatible with MRI and CT.
• Decurve shunts are fixed-pressure, burr-hole silicone shunts in pediatric and adult valve sizes, with a reservoir and no metal.
• Ventricular, peritoneal, ventriculoperitoneal, lumbar and lumboperitoneal catheter kits are available in standard and antibiotic-impregnated versions.
• The antisiphon device is designed to help prevent overdrainage by closing against the siphon effect that can occur when the peritoneal catheter moves from horizontal to vertical.

Experience during the bridge can inform these choices. A patient who needed a particular drainage threshold, or who showed sensitivity to changes in drainage, may influence the surgeon's view on fixed versus adjustable valves.

Why does continuity across the bridge matter?

The bridge involves two phases, two sets of devices and often two teams: neurocritical care during drainage and the neurosurgical team for shunting. Continuity reduces friction. When the drain and the shunt catheters come from the same manufacturer, surgeons see consistent catheter materials and tantalum markings, the antibiotic-impregnated option is identified the same way in both phases, and the hospital has one documentation set and one support contact for the whole pathway.

Handoff between the two teams also benefits. When the neurocritical care team documents the drainage threshold, output pattern and any clamping trial results, and the neurosurgical team can relate those findings to the valve options it knows well, the decision about pressure setting and valve type is better informed.

Continuity is not a reason to choose a product on its own; each device must suit the patient and the surgeon. But where the products are suitable, a single pathway is simpler for staff and for supply chain.

What should distributors understand about this pathway?

Distributors do not decide when a patient moves from drainage to shunting, but understanding the pathway makes them more useful. It explains why EVD volume and shunt volume are linked in the same hospitals, why neurosurgeons ask about valves while a patient is still on a drain, and why shunt revisions for infection bring EVD use with them. It also shows where stock is needed: drainage systems in the neuro-ICU, shunts and catheter kits in the OR, and both catheter types in both places.

Talk to a DESU product specialist

If you support hospitals that manage hydrocephalus from emergency drainage to shunting, DESU's product specialists can walk you through the drainage, catheter and shunt range and discuss support for your market. Write to sales@desu.tr or reach the team through the contact page.